Skip to main content
Equibles
ALGN logo

ALGN · Align Technology Inc

Track ALGN — free

Use ALGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$145.35 +1.34 (+0.93%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.30B
Shares
71.04M
Volume · Sep 30 917.82K Avg daily vol (3M) 917.5K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$145.35 Open$144.61 Day$142.83–146.68 52W close$125.22–197.51 Avg vol 30d901K Short int3.9M · 5.5% float · 4.9d Short vol73% Last earningsJul 29, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 4 wks
Latest filing: 10-Q
filed Aug 5, 2026
Q2 2026 earnings call transcript
call held Jul 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.14B
Trailing 12 months
Net income (TTM)
$413.58M
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
13.2%
Trailing 12 months
P / E (TTM)
25.1
Trailing earnings · reciprocal yield 4.0%
FCF yield
6.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.5%
Year over year · fewer shares
Price change (1Y)
+14.0%
Trailing year
Short interest
5.5%
Latest settlement · 4.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −15%
below
Price vs 50-day avg −10%
below
RSI (14) 39
neutral
MACD trend Positive
52-week position 28%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −6%
trailing
6-month return −17%
trailing
YTD return −7%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $161 › 200d $171 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +73 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.49% of float · ▲ +1.2% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
681 holders — near 3-yr low, contrarian setup
Squeeze score 62
elevated · 0–100
Fundamentals
Excellent
Revenue growth +24%
Y/Y
Gross margin 700%
contracting
EPS growth +1%
Y/Y
Free cash flow $490.8M
Valuation P/E 25.3
below peers
Buyback $733.3M
remaining
Quant / Vol
risk profile
Moderate
Volatility 40%
annualized · 1-yr
Max drawdown −27%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 5
Latest guidance · from the 8-K filed Jul 29, 2026
Q3'26
GAAP Gross Margin Initiated 67.5% – 68.5%
Non-GAAP Gross Margin Initiated 71%
GAAP Operating Margin Initiated 13.5% – 15%
fiscal 2026
Clear Aligner volume growth Initiated 6%
GAAP Operating Margin Initiated 15.1% – 15.6%
GAAP Gross Margin Initiated 70.2% – 70.5%
Capital expenditures Initiated $125M – $150M
Share repurchases Initiated $400M – $500M
Non-GAAP Operating Margin Initiated 23.7%
Q3 2026
Non-GAAP operating margin Initiated 24%
Fiscal 2026
Non-GAAP gross margin Initiated 71.7%
Guided vs delivered · last 5 settled
Worldwide revenues Q2'24
guided $1.03B – $1.05B
$1.03B Miss −1.1%
Worldwide revenues Q1'24
guided $960M – $980M
$997.43M Beat +2.8%
WW Revenue Q4'23
guided $920M – $940M
$956.73M Beat +2.9%
2023 WW Revenue full year 2023
guided $3.83B – $3.85B
$3.86B Beat +0.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−15% Bearish
Price vs 50-day avg
−10% Bearish
RSI (14)
39 Neutral
MACD trend
Positive Bullish
52-week position
28% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $161 › 200d $171 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +73 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.49% of float · ▲ +1.2% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
681 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $125 Now $145 · 28% Range high $198
vs 200-day avg -15% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ALGN
Align Technology Inc
this stock
$10.30B -6.9% +23.9% 25.3 5.5%
ISRG
Intuitive Surgical Inc
 $143.14B -28.2% +20.5% 46.5 2.3%
BDX
Becton Dickinson & Co
 $49.57B — +8.2% — 4.2%
MDLN
Medline Inc.
 $45.62B -17.4% +11.5% — 3.1%
RMD
Resmed Inc
 $32.02B -8.2% +13.4% 21.3 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
681
% held
103.7%
Net QoQ
+2.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
639
View
Short & Settlement
Short Interest Rising
Shares short
3.9M
Days to cover
4.9d
Change
+44.6K sh
View
Short Volume
Short vol %
73%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$248.7K
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
54.9%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Sep 11, 2025
View
Financials
Financials
Revenue (FY)
$4.0B
Net income (FY)
$410.4M
EPS diluted
$5.65
View
Buybacks
Authorized
$1.0B
Remaining
$733.3M
Spent Remaining
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Sep 15, 2026
This year
15
View
Proposed Sales
Value
$1.5M
Shares
8.0K
Filed
Feb 12, 2026
View
Earnings & Events
Earnings Calls
Last call
Sep 15, 2026
View

Performance

5D 20D 120D MTD YTD
ALGN -1.9% -6.2% -16.7% -9.0% -6.9%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -1.2% -6.3% -28.9% -8.5% -18.8%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$1.00B
Spent (derived)
$266.70M
Remaining
$733.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1097149 CUSIP 016255101 13F (30d) 18 filings 15 filers Visit website Investor relations